SCHEMBL20066639

SCHEMBL20066639

Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(c2)C(c2ccccc2)(C2(c4ccccc4)c4ccccc4-c4ccc(N(c5ccc(C)cc5)c5ccc(C)cc5)cc42)c2ccccc2-3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 7/20 0.38
▸ PTPRC P08575 1/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ ELANE P08246 1/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ OPRL1 P41146 1/20 0.31
▸ MAPT P10636 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066552 0.91 PDK2 (0.41) PDK2LMNACYP2C19OPRK1MAPT
SCHEMBL20066563 0.87 PDK2 (0.40) PDK2NPSR1LMNACYP2C19MAPT
SCHEMBL20066890 0.86 ALDH1A1 (0.41) PDK2CYP2C19MAPTKDM4EALDH1A1
SCHEMBL20066628 0.86 PDK2 (0.39) PDK2CYP2C19OPRM1MAPTKDM4E
SCHEMBL20066581 0.85 PDK2 (0.38) PDK2OPRM1
SCHEMBL16996126 0.85 ESR1 (0.41) PDK2PTPRCNPSR1KIF11LMNA
SCHEMBL18052476 0.85 ESR1 (0.41) PDK2PTPRCNPSR1KIF11LMNA
SCHEMBL20066647 0.85 PDK2 (0.38) PDK2KIF11CYP2C19MAPTKDM4E
SCHEMBL20066659 0.85 PDK2 (0.39) PDK2
SCHEMBL20076817 0.85 PDK2 (0.36) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-02 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1S, SCO2, CCND2 PDK2 1507/4885PTPRC 4712/4885NPSR1 3033/4885
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same C1S, SCO2, CCND2 PDK2 1507/4885PTPRC 4712/4885NPSR1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback